Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This research study is to evaluate the effectiveness, tolerability, and safety of lamotrigine
therapy in the treatment of binge eating disorder associated with obesity.
Lamotrigine has been approved by the Food and Drug Administration for the treatment of
bipolar disorder, but has not been approved for use in the treatment of binge eating disorder
with obesity.